Published in Antimicrob Agents Chemother on July 28, 2014
Neisseria gonorrhoeae antimicrobial susceptibility in Barcelona: penA, ponA, mtrR, and porB mutations and NG-MAST sequence types associated with decreased susceptibility to cephalosporins. Eur J Clin Microbiol Infect Dis (2016) 0.83
Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) for identification and clustering of Neisseria gonorrhoeae. BMC Microbiol (2015) 0.76
Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep (2012) 4.45
Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother (2011) 3.54
Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis (2004) 3.34
High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother (2011) 3.00
Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol (2012) 2.98
Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther (2009) 2.53
2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS (2013) 2.44
Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother (2009) 2.36
Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother (2012) 1.95
Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill (2010) 1.94
First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Euro Surveill (2011) 1.48
Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone. Euro Surveill (2013) 1.39
The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP)--a sentinel approach in the European Union (EU)/European Economic Area (EEA). Sex Transm Infect (2013) 1.34
Global resistance of Neisseria gonorrhoeae: when theory becomes reality. Curr Opin Infect Dis (2014) 1.14
Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance. Antimicrob Agents Chemother (2013) 1.11
Gonorrhea infection in women: prevalence, effects, screening, and management. Int J Womens Health (2011) 1.06
Gonorrhoea and gonococcal antimicrobial resistance surveillance networks in the WHO European Region, including the independent countries of the former Soviet Union. Sex Transm Infect (2013) 1.02
Phenotypic and molecular characterization of Neisseria gonorrhoeae isolates from Slovenia, 2006-12: rise and fall of the multidrug-resistant NG-MAST genogroup 1407 clone? J Antimicrob Chemother (2014) 1.02
Challenges with gonorrhea in the era of multi-drug and extensively drug resistance - are we on the right track? Expert Rev Anti Infect Ther (2014) 0.93
Phenotypic and genotypic characterization of Neisseria gonorrhoeae in parts of Italy: detection of a multiresistant cluster circulating in a heterosexual network. Clin Microbiol Infect (2008) 0.93
Preparing for an era of untreatable gonorrhea. Curr Opin Infect Dis (2014) 0.92
Gonococcal antimicrobial resistance: perspectives from the African region. Sex Transm Infect (2013) 0.90
Gonococcal antimicrobial resistance in the Western Pacific Region. Sex Transm Infect (2013) 0.89
Molecular analysis of tetracycline-resistant gonococci: rapid detection of resistant genotypes using a real-time PCR assay. FEMS Microbiol Lett (2008) 0.88
Cefixime and ceftriaxone susceptibility of Neisseria gonorrhoeae in Italy from 2006 to 2010. Clin Microbiol Infect (2011) 0.84
Disseminated gonococcal infection in an immunocompetent patient caused by an imported Neisseria gonorrhoeae multidrug-resistant strain. J Clin Microbiol (2006) 0.82
European surveillance of antimicrobial resistance in Neisseria gonorrhoeae. Sex Transm Infect (2010) 0.82
Emergence of multidrug-resistant Neisseria gonorrhoeae strains circulating worldwide. Int J Urol (2011) 0.78
ECDC public health response to the threat of resistant gonorrhoea in Europe. Euro Surveill (2012) 0.77
Update on antimicrobial susceptibility and genotype of Neisseria gonorrhoeae isolated in Italy. Diagn Microbiol Infect Dis (2012) 0.76
Typing of nosocomial outbreaks of Acinetobacter baumannii by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2012) 1.05
Screening for Chlamydia trachomatis and Neisseria gonorrhoeae among high-school participants using the Versant CT/GC DNA 1.0 assay (kinetic PCR). J Med Microbiol (2014) 0.78
LGV Chlamydia trachomatis serotypes: an update from Milan, Italy. Sex Transm Infect (2017) 0.75